PURE - PURE BIOSCIENCE, INC.

0.0687
0.000   0.437%

Share volume: 20,937
Last Updated: 05-11-2026
Chemicals/Misc. Chemical Products: 21.27%

PREVIOUS CLOSE
CHG
CHG%
$0.07
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
32%
Profitability 35%
Dept financing 43%
Liquidity 22%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.44%
1 Month
-16.93%
3 Months
30.86%
6 Months
24.91%
1 Year
16.44%
2 Year
5.69%
Key data
Stock price
$0.07
P/E Ratio 
N/A
DAY RANGE
$0.06 - $0.07
EPS 
-$0.01
52 WEEK RANGE
$0.04 - $0.21
52 WEEK CHANGE
$5.05
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
111.886 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
06-13-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$14,936
AVERAGE 30 VOLUME 
$25,524
Company detail
CEO:
Region: US
Website: purebio.com
Employees: 10
IPO year: 2013
Issue type:
Market: OTCM
Industry: Chemicals/Misc. Chemical Products
Sector: Manufacturing

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.

Recent news